Pharmafile Logo
Pharmafocus logo
Advanced Search

Quicker service for cancer patients but ‘black spots’ persist

March 2, 2005

Cancer patients are being seen more quickly but there is still room for improvement, says a National Audit Office report …

News

NICE acts to speed lung cancer diagnosis and treatment

March 2, 2005

Patients showing symptoms of lung cancer should be offered an urgent referral to a chest physician, according to NICE recommendations …

News

Singulair gains dual asthma-hayfever indication

March 2, 2005
Sales and Marketing

Merck Sharpe & Dohme's blockbuster oral asthma treatment Singulair has received an expanded UK licence for the treatment of adult …

News

NICE U-turn will ‘set Alzheimer’s treatment back 10 years’

March 2, 2005

News

NHS is behind us, says rep-free Takeda

March 1, 2005
Sales and Marketing Davis, Takeda, sales and marketing

Takeda UK says new market research shows healthcare professionals and NHS managers are in favour of its revolutionary move away …

News

Cymbalta approved for second indication

February 24, 2005
Sales and Marketing

Cymbalta has received European approval for diabetic peripheral neuropathic pain (DPNP) in adults, with its marketers keen to meet what …

News

Reassessing medical communications

February 24, 2005

It's time to be less defensive about perfectly legitimate medical communications methods providing contentious 'sharp practices' can be consigned to …

Feature

Private sector involvement in NHS continues to grow

February 24, 2005

News

Sankyo and Daiichi set to continue Japanese consolidation

February 24, 2005
Sales and Marketing

Two of Japan's leading pharmaceutical companies Sankyo and Daiichi look set to merge later this year, accelerating consolidation in the …

News

Novartis becomes generic world leader

February 24, 2005
Sales and Marketing

News

MHRA to get tough on ‘unethical’ pharma advertising

February 23, 2005

News

FDA panel clears Vioxx return to market

February 21, 2005
Sales and Marketing

An FDA panel has narrowly voted in favour of allowing Vioxx to return to the market, after concluding it carries …

News

IMS and Innovex announce UK alliance

February 17, 2005
Sales and Marketing

Pharma data consultants IMS have announced a new alliance with contract sales provider Innovex to supply its field forces with …

News

Garnier hints at large-scale cutbacks to global salesforce

February 17, 2005
Sales and Marketing

News

ADHD latest drugs to be hit by safety warnings

February 17, 2005
Sales and Marketing

Attention deficit hyperactivity disorder (ADHD) treatments are the latest class of drugs to be hit by safety warnings, with regulators …

News

New FDA drug safety board to be more independent

February 17, 2005
Sales and Marketing

A new independent FDA board will be set up to monitor drug safety and issue warnings to doctors and patients …

News

New customers: new education

February 16, 2005

Doctors have for a long time been the primary influencers of prescribing and chronic disease management. For pharma companies, that …

Feature

NHS to be key election issue as Blair unveils pledge

February 15, 2005
Blair, NHS

 Tony Blair has signalled Labour’s record on the NHS will be one of the key issues on which it will …

News

Chronic disease programme needs more work, says think tank

February 14, 2005

The new system of chronic disease management currently being piloted in ten PCTs needs further evaluation before it is extended …

News

Reid admits hospital closures a possibility

February 14, 2005

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026